{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:28:28Z","timestamp":1783027708835,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ijpharm.2014.07.030","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T19:59:12Z","timestamp":1406145552000},"page":"536-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Influence of pH and method of crystallization on the solid physical form of indomethacin"],"prefix":"10.1016","volume":"473","author":[{"given":"Alessandra","family":"Dubbini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Censi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Martena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ela","family":"Hoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Ricciutelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ledjan","family":"Malaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.07.030_bib0005","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jps.2600581004","article-title":"Determination of degree of crystallinity in solid-solid equilibria","volume":"58","author":"Allen","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3093(00)00107-1","article-title":"Crystal nucleation and growth of indomethacin polymorphs from the amorphous state","volume":"271","author":"Andronis","year":"2000","journal-title":"J. Non-Cryst. Sol."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0015","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1039\/an9952002627","article-title":"Kinetic study on degradation of indomethacin in alkaline aqueous solutions by derivative ultraviolet spectrophotometry","volume":"120","author":"Archontaki","year":"1995","journal-title":"Analyst"},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0020","first-page":"295","article-title":"The polymorphism of indomethacine. New modifications, their melting behavior and solubility","volume":"11","author":"Borka","year":"1974","journal-title":"Acta Pharm. Suec."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0025","doi-asserted-by":"crossref","first-page":"012","DOI":"10.1021\/ja017662o","article-title":"Reactivity differences of indomethacin solid forms with ammonia gas","volume":"124","author":"Chen","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jps.10028","article-title":"Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability","volume":"91","author":"Crowley","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0035","series-title":"Polymorphism in Pharmaceutical Solids","first-page":"227","article-title":"Theory and origin of polymorphism","author":"Grant","year":"1999"},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jps.2600660106","article-title":"Kinetics of indomethacin degradation I: presence of alkali","volume":"66","author":"Hajratwala","year":"1977","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejpb.2007.06.013","article-title":"Solubilization of indomethacin using hydrotropes for aqueous injection","volume":"68","author":"Jain","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0050","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1248\/cpb.33.3447","article-title":"Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol","volume":"33","author":"Kaneniwa","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0055","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1021\/ja00759a047","article-title":"Crystal and moleculr structure of an anti-inflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid","volume":"23","author":"Kistenmacher","year":"1972","journal-title":"J. Am.Chem. Soc."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5138\/ijdd.2010.0975.0215.03064","article-title":"Solubility enhancement of water insoluble drug for ophthalmic formulation","volume":"3","author":"Kulkarni","year":"2011","journal-title":"Int. J. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/B:JTAN.0000027824.55280.37","article-title":"Polymorphic and thermodynamic study of indomethacin","volume":"76","author":"Legendre","year":"2004","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1107\/S0021889807007832","article-title":"A new method for the reproducible generation of polymorphs: two forms of sulindac with very different solubilities","volume":"40","author":"Llin\u00e0s","year":"2007","journal-title":"J. Appl. Cryst"},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0075","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s11051-012-1275-9","article-title":"Indomethacin nanocrystals prepared by different laboratory scale methods: effect on crystalline form and dissolution behavior","volume":"14","author":"Martena","year":"2012","journal-title":"J.Nanopart. Res."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1081\/DDC-120003864","article-title":"Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug","volume":"28","author":"Mart\u00ednez-Oh\u00e1rriz","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2006.03.029","article-title":"Solid-state 13C NMR study of indomethacin polymorphism","volume":"318","author":"Masuda","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0090","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/jps.2600610918","article-title":"Use of adsorbents in enhancement of drug dissolution","volume":"61","author":"Monkhouse","year":"1972","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-5173(02)00083-2","article-title":"Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine","volume":"240","author":"Nair","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.addr.2003.10.008","article-title":"Drug polymorphism and dosage form design: a practical perspective","volume":"56","author":"Singhal","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0105","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1021\/mp400299a","article-title":"Indomethacin: new polymorphs of an old drug","volume":"10","author":"Surwase","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1023\/A:1018985110956","article-title":"Solid-state characteristics of amorphous sodium indomethacin relative to its free acid","volume":"16","author":"Tong","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt050226","article-title":"Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin","volume":"5","author":"Tong","year":"2004","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00097-7","article-title":"Crystalline solids","volume":"48","author":"Vippagunta","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1248\/cpb.16.17","article-title":"1-acyl-indoles. II. A new syntheses of 1-(ion-chlorobenzoyl)-5-methoxy-3-indolacetic acid and its polymorphism","volume":"16","author":"Yamamoto","year":"1968","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5173(02)00380-0","article-title":"Moisture induced polymorphic transition of mannitol and its morphological transformation","volume":"247","author":"Yoshinari","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(03)00157-1","article-title":"The improved compaction properties of mannitol after a moisture-induced polymorphic transition","volume":"258","author":"Yoshinari","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1461-5347(98)00031-5","article-title":"Physical characterization of polymorphic drugs: an integrated characterization strategy","volume":"1","author":"Yu","year":"1998","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(01)00098-9","article-title":"Amorphous pharmaceutical solids: preparation, characterization and stabilization","volume":"48","author":"Yu","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0150","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/jps.10225","article-title":"Glycine crystallization during spray drying the pH effect on salt and polymorphic forms","volume":"91","author":"Yu","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.07.030_bib0155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.addr.2003.10.009","article-title":"Phase transformation considerations during process development and manufacture of solid oral dosage forms","volume":"56","author":"Zhang","year":"2004","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314005298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314005298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T03:36:29Z","timestamp":1565667389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517314005298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0378517314005298"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.07.030","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of pH and method of crystallization on the solid physical form of indomethacin","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}